On the heels of FFL Partners’ $970 million acquisition of leading Canadian eye care provider New Look Vision last month, managing partner Chris Harris talks to Mergers & Acquisitions about the deal and the opportunity in this segment of the healthcare market. Lucrative roll up opportunities and organic growth prospects could bode well for the segment, just as General Catalyst-backed Warby Parker tests public market interest with an IPO expected this year.
To read the entire story, you must be logged in.
Please log in now or register with us.
